Description

Product Introduction of Miotepa – Thiotepa 15 mg Injection

Miotepa 15 mg Injection is used in the treatment of cancers of the brain, breast, lungs, and ovaries. It is often administered in combination with other cancer medications during hematopoietic progenitor cell transplantation (HPCT). Additionally, it may be used to treat other conditions as determined by your doctor.

Administration and Dosage

Miotepa 15 mg – Thiotepa 15 mg Injection

Injection is generally administered under the supervision of a healthcare professional. Your doctor will determine the appropriate dose and duration of treatment based on the severity of your condition and the specific illness being treated. It may take several weeks or months to notice the benefits, but do not discontinue the injection unless advised by your doctor.

Common Side Effects

The most common side effects of Miotepa 15mg Injection include:

• Decreased white blood cell count
• Anemia
• Low blood platelets
• Increased liver enzymes
• Elevated bilirubin levels in the blood
• Mucosal inflammation
• Hemorrhage
• Diarrhea
• Blood in urine
• Rash

This medication may reduce the number of blood cells, increasing the risk of infections. Regular blood tests are required to monitor your blood cells, as well as kidney, liver, and heart function during treatment.

Precautions

Before starting treatment with Miotepa 15 mg Injection, inform your doctor if you have any bleeding disorders, liver or kidney problems, or are taking any medications for infections. Miotepa can interact with many other medicines, so provide your doctor with a complete list of all the medications you are taking. This medicine is not recommended during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to avoid pregnancy.